In China's first-ever securities class action, Kangmei Pharmaceuticals has been ordered to pay $385 million as compensation—just enough for 50,000 investors to recoup their losses.
Data processors may not take biometric features as the sole method of authenticating individuals' identities. Anti-monopoly guidelines are set forth regarding the active pharmaceutical ingredient sector. Insurance capital may invest in REITs.
Jianwei (Jerry) Fang and Runyang Liu of Zhong Lun Law Firm highlight provisions from the newly released Measures for the Security Assessment of Overseas Transfer of Data (Draft for Comments) issued by the Cyberspace Administration of China (CAC) and discuss the issues arising out of outbound data transfer
Hong Kong IPOs also subject to cybersecurity review; social, sustainability bond issuance pilot for foreign issuers; and U.S. law bars new equipment licenses for Chinese telecoms firms
Apps are required to inform users of third party use of their personal information. CSRC issues registration rules for public offerings of shares on the Beijing Stock Exchange. Beijing Municipality issues rules to prohibit misappropriation of housing purchase funds.
Senior legal counsel discusses how IP rights must be proactively and creatively defended. China's strict scrutiny of its jewelry industry may further tighten, with specific AML rules expected to arrive in the near future.
